MB

Mita Banerjee

Director Director DIN 00724142
DIN 00724142 First appointment Oct 2001 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2001
Shareholding value •••• Premium profile

About Mita Banerjee

Data last updated:

Mita Banerjee was a Director at Banerjee Remedies Private Limited (2001–2024) and Director at Banerjee Distributors Private Limited (2008–2024). The companies operate in Pharma.

DIN 00724142
Primary Designation Director
Industry Pharma
First Appointment 23 Oct 2001

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Banerjee Remedies Private Limited U74900WB2001PTC093880
Director23 Oct 20012001₹3.72 Cr (FY 2025)Active
Director09 Sep 20082008₹45.77 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Banerjee Remedies Private Limited
Banerjee Distributors Private Limited
Premium access

Shareholding and investment profile for Mita Banerjee

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mita Banerjee

Mita Banerjee was first appointed on 23 Oct 2001 as Director at Banerjee Remedies Private Limited. The most recent appointment on record is 09 Sep 2008 at Banerjee Distributors Private Limited.

Mita Banerjee held 2 earlier board appointments: Banerjee Remedies Private Limited (Director, 23 Oct 2001 to 23 Oct 2024); Banerjee Distributors Private Limited (Director, 09 Sep 2008 to 23 Oct 2024).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available